Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Abelleira

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Reviews in Endocrine & Metabolic Disorders|November 28, 2023
Dynamic risk assessment in patients with differentiated thyroid cancerErika Abelleira, Fernando Jerkovich
Endocrine|May 27, 2024
Primary resistance to selpercatinib in a patient with advanced medullary thyroid cancerFabian Pitoia, Pierpaolo Trimboli, Erika Abelleira
Endocrine|September 23, 2016
Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSHFabian Pitoia, Erika Abelleira, Graciela Cross
European Thyroid Journal|March 12, 2015
Recombinant human thyroid-stimulating hormone-aided remnant ablation achieves a response to treatment comparable to that with thyroid hormone withdrawal in patients with clinically relevant lymph node metastasesFabián Pitoia, Erika Abelleira, Graciela Cross
Endocrine|August 6, 2020
Thyroid cancer in the Era of COVID-19Anabella Smulever, Erika Abelleira, Fernanda Bueno, et al.
Medicina|September 5, 2014
[Thyroid dysfunction in adults infected by human immunodeficiency virus]Erika Abelleira, Graciela A De Cross, Fabián Pitoia
Endocrine|May 21, 2024
Ten years' real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancerFernando Jerkovich, Soledad Capalbo, Erika Abelleira, et al.
Endocrine|July 13, 2026
Anaplastic thyroid carcinoma in Argentina: real-world diagnostic lags and treatment barriersAnabella Smulever, Fabián Pitoia, Erika Abelleira, et al.
Endocrinologia, Diabetes Y Nutricion|June 15, 2020
Role of <sup>18</sup>F-FDG-PET/CT in patients with differentiated thyroid cancer with biochemical incomplete or indeterminate response to treatmentErika Abelleira, María Gabriela García Falcone, Fernanda Bueno, et al.
Archives of Endocrinology and Metabolism|January 10, 2019
Rare complications of multikinase inhibitor treatmentFabián Pitoia, Angélica Schmidt, Fernanda Bueno, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Reviews in Endocrine & Metabolic Disorders|November 28, 2023
Dynamic risk assessment in patients with differentiated thyroid cancerErika Abelleira, Fernando Jerkovich
Endocrine|May 27, 2024
Primary resistance to selpercatinib in a patient with advanced medullary thyroid cancerFabian Pitoia, Pierpaolo Trimboli, Erika Abelleira
Endocrine|September 23, 2016
Thyroglobulin levels measured at the time of remnant ablation to predict response to treatment in differentiated thyroid cancer after thyroid hormone withdrawal or recombinant human TSHFabian Pitoia, Erika Abelleira, Graciela Cross
European Thyroid Journal|March 12, 2015
Recombinant human thyroid-stimulating hormone-aided remnant ablation achieves a response to treatment comparable to that with thyroid hormone withdrawal in patients with clinically relevant lymph node metastasesFabián Pitoia, Erika Abelleira, Graciela Cross
Endocrine|August 6, 2020
Thyroid cancer in the Era of COVID-19Anabella Smulever, Erika Abelleira, Fernanda Bueno, et al.
Medicina|September 5, 2014
[Thyroid dysfunction in adults infected by human immunodeficiency virus]Erika Abelleira, Graciela A De Cross, Fabián Pitoia
Endocrine|May 21, 2024
Ten years' real-life experience on the use of multikinase inhibitors in patients with advanced differentiated thyroid cancerFernando Jerkovich, Soledad Capalbo, Erika Abelleira, et al.
Endocrine|July 13, 2026
Anaplastic thyroid carcinoma in Argentina: real-world diagnostic lags and treatment barriersAnabella Smulever, Fabián Pitoia, Erika Abelleira, et al.
Endocrinologia, Diabetes Y Nutricion|June 15, 2020
Role of <sup>18</sup>F-FDG-PET/CT in patients with differentiated thyroid cancer with biochemical incomplete or indeterminate response to treatmentErika Abelleira, María Gabriela García Falcone, Fernanda Bueno, et al.
Archives of Endocrinology and Metabolism|January 10, 2019
Rare complications of multikinase inhibitor treatmentFabián Pitoia, Angélica Schmidt, Fernanda Bueno, et al.
Pageof 3